Immuron Ltd ADR

Immuron Limited is a biopharmaceutical company focused on the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments: Research and Development, and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders, and Protectyn, an immune supplement for digestive and liver health. It is developing Travelan (IMM-124E) and IMM-529, both in Phase II clinical trials, as well as IMM-986 in pre-clinical development. Immuron collaborates with the US Naval Medical Research Command and the Walter Reed Army Institute of Research. Formerly known as Anadis Limited, it changed its name to Immuron Limited in December 2008, was incorporated in 1994, and is headquartered in Carlton, Australia.